Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time

Transpl Int. 2016 Apr;29(4):425-31. doi: 10.1111/tri.12719. Epub 2015 Dec 22.

Abstract

To assess the impact of shipping distance and cold ischaemia time (CIT) of shipped organs in a kidney paired donation (KPD) programme, we evaluated the outcomes of the initial 100 kidney transplants performed in the Australian KPD programme. In a 44-month period, 12 centres were involved in fifteen 2-way, twenty 3-way, one 4-way and one 6-way exchanges. Sixteen kidneys were transplanted at the same hospital (CIT 2.6 ± 0.6 h) and 84 required transport to the recipient hospital (CIT 6.8 ± 2.8 h). A spontaneous fall in serum creatinine by at least 10% within 24 h was observed in 85% of recipients, with no difference between nonshipped and shipped kidneys. There were two cases of transient delayed graft function requiring dialysis and patient and graft survival at 1 year were 99% and 97%, respectively. There was no difference in recipients of nonshipped compared with shipped kidneys with regard to serum creatinine at 1 month (mean difference (MD) 7.3 μmol/l, 95% CI -20.2 to 34.8, P = 0.59), 1-year graft survival (MD 3.9%, 95% CI -5.4 to 13.2, P = 0.41) or patient survival (MD -2.4%, 95% CI -10.0 to 5.2, P = 0.54). Despite prolonged CIT for interstate exchanges, the programme's decision to ship donor kidneys rather than the donor appears to be safe.

Keywords: cold ischaemia time; delayed graft function; kidney paired donation; living-donor kidney transplantation; organ transport.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Australia
  • Cold Ischemia*
  • Creatinine / blood
  • Delayed Graft Function
  • Female
  • Graft Survival
  • Humans
  • Kidney Transplantation / methods*
  • Living Donors
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Organ Preservation / methods*
  • Registries
  • Renal Insufficiency / surgery*
  • Time Factors
  • Tissue and Organ Harvesting / methods*
  • Treatment Outcome

Substances

  • Creatinine